Corticosterone
In clinical developmentAlso known as 17-deoxycortisol, Compound B, Kendall's compound B, Reichstein's substance H+1 more
17-deoxycortisol, Compound B, Kendall's compound B, Reichstein's substance H, 11beta,21-Dihydroxy-4-pregnene-3,20-dione.
Recent clinical, regulatory, research and industry developments relating to this drug.
Regulating the Plasticity of Hippocampal Neurons via Electroacupuncture in Depression Model Mice.
Ketamine induced synaptic plasticity operates independently of long-term potentiation.
Generalized fear after acute stress is caused by change in neuronal cotransmitter identity.
Identification of a prefrontal cortex-to-amygdala pathway for chronic stress-induced anxiety.
Identification of targets of leptin action in rat hypothalamus.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Cell proliferation1
- Cells1
- Nature communications1
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology1
- Proceedings of the National Academy of Sciences of the United States of America1
- Science (New York, N.Y.)1
- Abdel-Hafiz L1
- Ali AAH1
- Anstötz M1
- Baskin DG1
- Bossi S1
- Burn P1
- Campfield LA1
- Cardoso C1
- Institut de Biologie de l'Ecole Normale Supérieure1
- Institut du Fer à Moulin1
- Institute of Anatomy and Cell Biology1
- Institute of Anatomy II1
- Institute of Materiobiology1
- Institute of Neuroanatomy and Cell Biology1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Corticosterone in the shared literature.
Studied across 2 of the same disease areas as Corticosterone in the shared literature.
Studied across the same disease area as Corticosterone in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials